American International Group, Inc. Entrada Therapeutics, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$11.58 - $17.0 $1,042 - $1,530	-90 Reduced 0.85%	10,546 $149,000
Q4 2023 Feb 13, 2024	SELL	$11.36 - $16.99 $488 - $730	-43 Reduced 0.4%	10,636 $160,000
Q3 2023 Nov 13, 2023	BUY	$13.61 - $18.01 $5,171 - $6,843	380 Added 3.69%	10,679 $168,000
Q2 2023 Aug 04, 2023	BUY	$11.02 - $18.01 $113,494 - $185,484	10,299 New	10,299 $155,000
Q2 2022 Aug 12, 2022	SELL	$5.49 - $12.94 $28,674 - $67,585	-5,223 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.99 - $16.93 $2,844 - $6,027	356 Added 7.31%	5,223 $49,000
Q4 2021 Feb 11, 2022	BUY	$13.7 - $35.0 $66,677 - $170,345	4,867 New	4,867 $83,000

27.7M

100

Ticker TRDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,368,500
Market Cap $502M
Description
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.